Multiple Sclerosis Therapeutics, 3 edition
Multiple Sclerosis Therapeutics, 3 edition by Jeffrey A. Cohen, Richard A. Rudick
English | 2007 | 928 Pages | ISBN: 1841845256 | PDF | 7 MB
English | 2007 | 928 Pages | ISBN: 1841845256 | PDF | 7 MB
Multiple Sclerosis Therapeutics, Third Edition provides a comprehensive update of clinical trial methodology and current therapeutic modalities in multiple sclerosis. This new edition has been thoroughly revised and reorganized by the team of international contributors to reflect advances in understanding of the pathophysiology of the disease and to include new and emerging treatments. New chapters have been included on biomarkers in MS, pharmacogenomics, emerging therapeutic modalities (natalizumab, T-cell-based therapies, B-cell-based therapies, cytokine/chemokine-based therapies, statins, 4-aminopyridine), neuroprotection, and the use of OCT and MRI to guide disease therapy.
The most comprehensive textbook on clinical trial methodology and treatment outcomes in multiple sclerosis, Multiple Sclerosis Therapeutics is a highly useful resource for neurologists and anyone involved in the treatment of multiple sclerosis.
My nickname - interes